HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Soy, Selenium Claims Should Perhaps Be Expanded, Not Weakened – CRN

This article was originally published in The Tan Sheet

Executive Summary

The Council for Responsible Nutrition recommends FDA maintain the health claim linking soy protein and reduced heart disease risk and consider adding language to address the "possible contribution" of other soy components

You may also be interested in...

Soy Protein Under Fire, But Experts, Industry Confident In Heart Health Claim

Nutrition experts say a citizen petition requesting FDA revoke a health claim linking soy protein to heart health benefits weakens its own argument by citing data selectively and in error

Emord Extends Effort To Liberalize QHCs With Selenium, Antioxidant Petitions

Attorney Jonathan Emord continues his effort to force FDA to allow more expansive qualified health claims for nutritional supplements with two petitions relating to the capability of selenium and antioxidant vitamins to reduce the risk of site-specific cancers

FDA Health Claims Draft Guidance Should Value Totality Of Evidence – CRN

FDA's apparent contention that results from randomized controlled trials invalidate conflicting information from observational studies on the effects of nutrients reflects "an intrinsic bias" within the agency or "a lack of fundamental understanding of research methods," according to the Council for Responsible Nutrition

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts